About Darmiyan
Darmiyan is a company based in San Francisco (United States) founded in 2015. Darmiyan has raised $10.09 million across 3 funding rounds from investors including Y Combinator, IT-Farm Corporation and Eisai Innovation. Darmiyan offers products and services including BrainSee Software and Alzheimer’s Test. Darmiyan operates in a competitive market with competitors including Siemens Healthineers, Inscopix, Artiria, RetiSpec and VISIE, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Darmiyan, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.09 M (USD)
in 3 rounds
-
Latest Funding Round
$3.54 M (USD), Seed
Oct 17, 2023
-
Investors
Y Combinator
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Darmiyan
Darmiyan offers a comprehensive portfolio of products and services, including BrainSee Software and Alzheimer’s Test.
AI software for predicting cognitive decline via MRI analysis
Non-invasive tool for early detection of neurodegenerative diseases
People of Darmiyan
Unlock access to complete
Unlock access to complete
Funding Insights of Darmiyan
Darmiyan has successfully raised a total of $10.09M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3.54 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Darmiyan
Darmiyan has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Y Combinator, IT-Farm Corporation and Eisai Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Early-stage tech investments are directed toward Asia and the US.
|
Locked | Locked | Locked | |
|
Private equity firm focused on biotech and healthcare sectors
|
Locked | Locked | Locked |
Investor details for Darmiyan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Darmiyan
Investment portfolio details for Darmiyan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Darmiyan
Detailed financials for Darmiyan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Darmiyan Comparisons
Peer comparison for Darmiyan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Darmiyan
Darmiyan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siemens Healthineers, Inscopix, Artiria, RetiSpec and VISIE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
Detailed competitors of Darmiyan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Darmiyan
Complete news archive for Darmiyan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Darmiyan
Darmiyan was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Darmiyan is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Darmiyan is a funded company, having raised a total of $10.09M across 3 funding rounds to date.
Founded in 2015 and based in San Francisco, United States, Darmiyan operates within the health technology sector focused on neuroimaging. A platform is provided for early detection of neurodegenerative disorders, enabling precise measurement and pinpointing of brain irregularities. Distribution patterns in the brain are mapped dynamically to support evaluation of new pharmaceuticals and biological compounds. MRI scans are analyzed to detect regions of neural decline.
Darmiyan's top competitors include Siemens Healthineers, Inscopix and RetiSpec.
Darmiyan offers BrainSee Software and Alzheimer’s Test.
Darmiyan has 3 investors. Key investors include Y Combinator, IT-Farm Corporation, and Eisai Innovation.